10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
PLEASANTON, Calif., Oct. 25, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2019 after market close on Thursday, November 7, 2019. Company management will host a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its results, business developments and outlook. Analysts, investors and other parties interested in listening to the conference call may do so by dialing (877) 665-6515 for domestic callers or (602) 563-8470 for international callers, using conference ID: 5899936. A live and archived webcast of the event will be available at https://investors.10xgenomics.com/ for at least 14 days following the event. About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Morgan Stanley from $28.00 to $26.00. They now have an "overweight" rating on the stock.MarketBeat
- 10x Genomics, Inc. (NASDAQ: TXG) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.MarketBeat
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $20.00 to $18.00. They now have a "buy" rating on the stock.MarketBeat
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Citigroup Inc. from $23.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at JPMorgan Chase & Co. from $14.00 to $12.00. They now have a "neutral" rating on the stock.MarketBeat
TXG
Earnings
- 2/12/25 - Miss
TXG
Sec Filings
- 2/13/25 - Form S-8
- 2/13/25 - Form 10-K
- 2/12/25 - Form 8-K
- TXG's page on the SEC website